Jaguar Health MVID trial moves to extension phase ahead of 2027 NDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. TSLA
5. USO
6. AMD
7. META
8. AMC
9. PSKY
10. NUAI

Go back to Jaguar Health MVID trial moves to extension phase ahead of 2027 NDA
(NASDAQ: JAGX) Delayed: 2.58 -0.13 (4.8%)
Previous Close $2.71    52 Week High $4.60 
Open $2.87    52 Week Low $0.81 
Day High $2.87    P/E N/A 
Day Low $2.50    EPS $0.00 
Volume 46,929